Home Authors Posts by Sarah Pringle

Sarah Pringle

The contract-sales business of Quintiles IMS is fielding looks from a limited group of sponsors and strategics, three sources told Buyouts. Quintiles, Danbury, Connecticut, is projecting the contract-sales business will generate adjusted EBITDA of about $60 million to $65 million in 2017, the people said. The unit is projected to generate just shy of $800 […]
Carlyle Group, Newport Academy, private equity, merger, M&A, healthcare
Carlyle has struck a deal to acquire Newport Academy, which treats teens suffering from conditions ranging from trauma and depression to drug and alcohol abuse, three sources told Buyouts. The Washington firm is said to be acquiring the company legally registered as Monroe Operations LLC through its U.S. Equity Opportunity Fund. Carlyle’s second North American […]
Private equity firm Ares Management is close to buying the practice-management company of Summit Partners-backed DuPage Medical Group, according to a Hart-Scott-Rodino early termination notice. The filing with the FTC follows a July 14 Buyouts report that New York’s Ares was the frontrunner in a process for the Chicago multispecialty physician group. The HSR filing shows that […]
Thomas H. Lee, Lee Equity Partners, Chris Witkowsky, private equity
Fund I closed in 2008 at ~$1.1 bln An interim bridge fund raised at least $315 mln in 2016 New York firm promoted five team members in February Lee Equity Partners plans to raise its next fund in 2018, the firm’s founder, Thomas H. Lee, said at Emerging Manager Connect East. Lee also indicated he would move out […]
TPG’s recent deal for ed-tech startup EverFi reflects an emerging trend that one partner says the firm is well positioned to exploit. That trend, said TPG Partner Nehal Raj, is more cross-pollination between what would traditionally be thought of as growth equity and buyouts. In other words, more companies that have previously chosen to go public — those that […]
TPG’s recent deal for ed-tech startup EverFi reflects an emerging trend that one partner says the firm is well positioned to exploit. That trend, said TPG Partner Nehal Raj, is more cross-pollination between what would traditionally be thought of as growth equity and buyouts. In other words, more companies that have previously chosen to go public — those that […]
Madison Capital, Adam Willis, private equity, merger, M&A
Healthcare makes up >20% of lender’s portfolio Unrealistic value expectations of “me too” companies lead to failed processes Diverse pool of capital providers drives up debt multiples Adam Willis serves as a managing director at Madison Capital Funding, where he heads up the lender’s healthcare efforts and leads a dedicated team. Madison, with more than […]
MTS Health Investors is exploring the sale of Celerion less than three years after investing in the Phase 1-focused contract research organization, according to three sources familiar with the matter. The healthcare private equity firm has retained Lazard to advise on a process, the sources said. Lazard knows Celerion well, having conducted the process that […]
Nehal Raj
Q2 sees 127 announced PE deals vs. 75 in Q1; dollar volume also spikes Tech produces highest number of closed transactions TPG among most active in tech, supported by 3 funds with 3 different mandates A high-price environment hasn’t stopped traditional private equity firms from finding new investments, with sponsor-led dealmaking in tech fueling a […]
Welsh, Carson, Anderson & Stowe is looking to exit its more than decade-long investment in Aptuit LLC, a provider of early- and mid-phase clinical drug-development services, three sources familiar with the matter said. The contract research organization is projecting 2017 adjusted revenue and EBITDA of $126 million and $25 million, respectively, the sources said. William […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination